RxDoctor Payments Data

John Martin-Beaulieu, APRN

Nurse Practitioner · Hartford, CTNPI 1699203745

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (48.0%), food and beverage and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 89.1% of it on its own, with 7 other manufacturers making up the rest. Among nurse practitioner clinicians in CT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,573in general payments, 2019–2025

Across 52 payments — averaging $87.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$4K
  • Biotronik Inc.$204
  • Biosense Webster, Inc.$110
  • E.r. Squibb & Sons, L.L.C.$58
  • Abbott$53
  • Sanofi-aventis U.S. LLC$37
  • plus $36 from 2 others

What the payments were for

  • Travel & lodging$2,19548%
  • Food & beverage$2,02144%
  • Education$3578%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,573 in reported general payments places this provider in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.

See all nurse practitioner providers in Connecticut

Medicare billing

Part B allowed, 2024
$17,053
Medicare patients
135
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban70$85,299
Dofetilide174$46,713
XareltoRivaroxaban16$12,431
Flecainide Acetate66$3,654
Mexiletine Hcl18$2,786
Ranolazine ErRanolazine34$2,303
SotalolSotalol Hcl78$1,955
Metoprolol Succinate111$1,272
Diltiazem 24hr Er (Cd)Diltiazem Hcl33$1,030
Amiodarone Hcl40$669
Atenolol13$137
Metoprolol Tartrate31$132
Amlodipine Besylate11$41

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Hartford

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →